Tarsus Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TARS for the last quarter is 27.61 M USD, and it's 111.18% higher compared to the previous quarter. The net income of Q1 24 is -35.73 M USD.